Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a ...

Some outside researchers were less reserved. Clinical trials using CRISPR gene editing have been underway for nearly a decade. But like most trials, they focused on broad groups of patients.

A baby boy with a devastating genetic disease is thriving after becoming the first known person to receive a bespoke, CRISPR therapy-for-one, designed to correct his specific disease-causing ...

A US court just put ownership of CRISPR back in play The CRISPR patents are back in play. Yesterday, the US Court of Appeals for the Federal Circuit said scientists Jennifer Doudna and Emmanuelle ...

CRISPR Therapeutics has begun realizing sales on Casgevy, its first therapy and a joint venture with Vertex Pharmaceuticals. The company has plenty of cash to fund research and development for the ...

G ene therapy has always held enormous promise to correct genetic diseases, but turning that potential into treatments has ...

The Board concluded that the Regents failed to conceive of the invention before the Broad’s reduction to practice on October 5, 2012, because their scientists lacked confidence that the CRISPR ...

Stem cell therapy shows early promise for treating Parkinson's. Discover who is in the race to bring this breakthrough to ...

The U2724DE has an IPS Black panel that roughly doubles the monitor’s contrast ratio (compared to other IPS monitors). It can’t beat a more expensive OLED or Mini-LED panel, but it’s still ...

CRISPR Therapeutics has an approved gene-therapy treatment still in its early growth stages. One of them is CRISPR Therapeutics (NASDAQ: CRSP). Its financials haven't been looking all that ...